Fenofibrate Grofibrat only here is not can utilized for use in patients with hepatic impairment due to the lack this list data. Fenofibrate comes in different Grofibrat of capsules and tablets which provide different amounts of the medication. Additionally, because fenofibrate therapy has been associated with elevations in serum creatinine, renal monitoring should be considered in patients at increased risk for renal impairment including those with diabetes. Other inflammatory markers such as C Reactive Protein are reduced with fenofibrate treatment.
Possible side effects of Grofibrat include:
Grofibrat is used to treat diseases such as: Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa, Elevated LDL, Hyperlipoproteinemia Type IIb, Elevated LDL VLDL, Hyperlipoproteinemia Type IV, Elevated VLDL, Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL, Hypertriglyceridemia.
Make sure that they take it all. Some patients may receive additional benefit by increasing the dose to 15 mg once daily.